Infliximab for patients with neuro-Behcet's disease: case series and literature review.
Borhani Haghighi A, Safari A, Nazarinia MA, Habibagahi Z, Shenavandeh S.
Borhani Haghighi A, et al. Among authors: shenavandeh s.
Clin Rheumatol. 2011 Jul;30(7):1007-12. doi: 10.1007/s10067-011-1726-1. Epub 2011 Mar 24.
Clin Rheumatol. 2011.
PMID: 21431864
Review.
This study aims to report the therapeutic effects of anti-tumor necrotic factor antibody, infliximab, for treatment of neuro-Behcet's disease (NBD) and to review the literature. We described four patients (all male, median age 40 years old) who fulfilled the International …
This study aims to report the therapeutic effects of anti-tumor necrotic factor antibody, infliximab, for treatment of neuro-Behcet's …